2011 pharma-biotech predictions
Scientia Advisors in the News
Predictions for 2011: Troublesome transition year for pharma-biotech playerspartneringNEWS
January 5, 2011
To mark the changing of the calendar year, partneringNEWS asked four biotech industry gurus, including Harry Glorikian of Scientia Advisors, to gaze into their crystal ball for a glimpse of what may come to pass in 2011, and beyond.
Based on their prognostications, pharma continues to have its work cut out to not only soften the blow from looming patent expirations, but perhaps more importantly, to survive in the emerging health outcomes ecosystem.
Read on and discover key upcoming trends shaping the pharmaceutical and diagnostic industries: partneringNEWS